How should we respond to the emergence of plasmid-mediated colistin resistance in humans and animals?
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: The widespread use of antibiotics in humans and animals has contributed to growing rates of antibiotic resistance. Previously treatable bacterial infections now require the last line of antibiotics or are untreatable. The current antibiotic of last resort for carbapenem-resistant Gram-negative bacterial infections is often colistin. Evidence for the shifting pattern of colistin resistance and how the international community should respond are discussed in this review. METHODS: The literature on colistin resistance was reviewed. RESULTS: Plasmid-mediated colistin resistance encoded by mcr-1 was first documented in China during the routine surveillance of food animals. This has been followed by similar reports across a wide geographic area, in humans, animals, and the environment. The mcr-1 gene has been reported among human isolates in 29 countries, related to environmental samples in four countries, and in food animals and other animals in 28 countries. More recently, a second gene encoding resistance, mcr-2, has been isolated from porcine and bovine Escherichia coli. CONCLUSION: The emergence and horizontal transmission of colistin resistance highlights the need for heightened stewardship efforts across the One Health platform for this antibiotic of last resort, and indeed for all antibiotics used in animals and humans.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lo-Ten-Foe, J. R., de Smet, A. M. G. A., Diederen, B. M. W., Kluytmans, J. A. J. W., & van Keulen, P. H. J. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01406-06 · Cited by 242
Silvestri, L., de la Cal, M. A., & van Saene, H. K. F. (2012) · Intensive Care Medicine · doi:10.1007/s00134-012-2690-1 · Cited by 111
Kluyvera ascorbata Strain from Hospital Sewage Carrying the mcr-1 Colistin Resistance Gene
Zhao, F., & Zong, Z. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01165-16 · Cited by 53
Cited by
Distribution of antibiotic resistance genes in the environment
Zhuang, M., Achmon, Y., Cao, Y., Liang, X., Chen, L., Wang, H., Siame, B. A., & Leung, K. Y. (2021) · Environmental Pollution · doi:10.1016/j.envpol.2021.117402 · Cited by 422
Global geographic trends in antimicrobial resistance: the role of international travel
Frost, I., Van Boeckel, T. P., Pires, J., Craig, J., & Laxminarayan, R. (2019) · Journal of Travel Medicine · doi:10.1093/jtm/taz036 · Cited by 338
Self-citationTargeting Metalloenzymes for Therapeutic Intervention
Chen, A. Y., Adamek, R. N., Dick, B. L., Credille, C. V., Morrison, C. N., & Cohen, S. M. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00201 · Cited by 270
Osei Sekyere, J., Maningi, N. E., Modipane, L., & Mbelle, N. M. (2020) · mSystems · doi:10.1128/msystems.00148-20 · Cited by 47
“The diversity of species and plasmids involved in the dissemination of this gene explains its promiscuity and rapid spread around the globe, further corroborating the need to restrict the use of colistin in both veterinary and human medicine (5, 28).”
Metadata
- Authors
- Al-Tawfiq, J. A., Laxminarayan, R., & Mendelson, M.
- Venue
- International Journal of Infectious Diseases
- Publisher
- Elsevier BV
- Published
- 2017-01
- Volume
- 54
- Pages
- 77-84
- ISSN
- 1201-9712 (ISSN-L)
- OpenAlex
- W2558715379
- Cited by
- 142
- References
- 3
- FWCI
- 9.22
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: How should we respond to the emergence of plasmid-mediated colistin resistance in humans and animals? https://app.cochat.ai/papers/10.1016/j.ijid.2016.11.415
- The paper
- Al-Tawfiq, J. A., Laxminarayan, R., & Mendelson, M. (2017). How should we respond to the emergence of plasmid-mediated colistin resistance in humans and animals? International Journal of Infectious Diseases. https://doi.org/10.1016/j.ijid.2016.11.415
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.